Skip to main content
. 2014 Jan;52(1):139–146. doi: 10.1128/JCM.02452-13

FIG 2.

FIG 2

Schematic representation of the workflow anticipated after adoption of whole-genome sequencing used either on cultured isolates or directly on the clinical samples, with an expected time scale.